These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32799457)

  • 1. Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues.
    Chen S; Yao H; Zhou Q; Tse MK; Gunawan YF; Zhu G
    Inorg Chem; 2020 Aug; 59(16):11676-11687. PubMed ID: 32799457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride.
    Xu Z; Chan HM; Li C; Wang Z; Tse MK; Tong Z; Zhu G
    Inorg Chem; 2018 Jul; 57(14):8227-8235. PubMed ID: 29943979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules.
    Babu T; Sarkar A; Karmakar S; Schmidt C; Gibson D
    Inorg Chem; 2020 Apr; 59(7):5182-5193. PubMed ID: 32207294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond mere DNA damage: Recent progress in platinum(IV) anticancer complexes containing multi-functional axial ligands.
    Deng Z; Zhu G
    Curr Opin Chem Biol; 2023 Jun; 74():102303. PubMed ID: 37075513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of axial ligands to promote the photoactivation of BODIPY-conjugated platinum(IV) anticancer prodrugs.
    Yao H; Gunawan YF; Liu G; Tse MK; Zhu G
    Dalton Trans; 2021 Oct; 50(39):13737-13747. PubMed ID: 34519297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promising Anticancer Prodrugs Based on Pt(IV) Complexes with Bis-organosilane Ligands in Axial Positions.
    Navas F; Chocarro-Calvo A; Iglesias-Hernández P; Fernández-García P; Morales V; García-Martínez JM; Sanz R; De la Vieja A; García-Jiménez C; García-Muñoz RA
    J Med Chem; 2024 Apr; 67(8):6410-6424. PubMed ID: 38592014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation of anticancer Pt(II) complexes with monodentate phosphane ligands: towards stable but active Pt(IV) prodrugs.
    Medrano MÁ; Álvarez-Valdés A; Perles J; Lloret-Fillol J; Muñoz-Galván S; Carnero A; Navarro-Ranninger C; Quiroga AG
    Chem Commun (Camb); 2013 May; 49(42):4806-8. PubMed ID: 23591566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs.
    Yap SQ; Chin CF; Hong Thng AH; Pang YY; Ho HK; Ang WH
    ChemMedChem; 2017 Feb; 12(4):300-311. PubMed ID: 28028938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multitargeted Platinum(IV) Anticancer Complexes Bearing Pyridinyl Ligands as Axial Leaving Groups.
    Zhou Q; Chen S; Xu Z; Liu G; Zhang S; Wang Z; Tse MK; Yiu SM; Zhu G
    Angew Chem Int Ed Engl; 2023 Apr; 62(18):e202302156. PubMed ID: 36878864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What do we know about the reduction of Pt(IV) pro-drugs?
    Wexselblatt E; Gibson D
    J Inorg Biochem; 2012 Dec; 117():220-9. PubMed ID: 22877926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the Inertness to Hydrolysis of Platinum(IV) Prodrugs.
    Ritacco I; Mazzone G; Russo N; Sicilia E
    Inorg Chem; 2016 Feb; 55(4):1580-6. PubMed ID: 26812023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of Pt(IV) fluorescein conjugates to investigate Pt(IV) intracellular transformations.
    Song Y; Suntharalingam K; Yeung JS; Royzen M; Lippard SJ
    Bioconjug Chem; 2013 Oct; 24(10):1733-40. PubMed ID: 23957697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of different carbonate ligands on the hydrolytic stability and reduction of platinum(IV) prodrugs.
    Chen S; Ng KY; Zhou Q; Yao H; Deng Z; Tse MK; Zhu G
    Dalton Trans; 2022 Jan; 51(3):885-897. PubMed ID: 34927657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative Stress Induced by Pt(IV) Pro-drugs Based on the Cisplatin Scaffold and Indole Carboxylic Acids in Axial Position.
    Tolan D; Gandin V; Morrison L; El-Nahas A; Marzano C; Montagner D; Erxleben A
    Sci Rep; 2016 Jul; 6():29367. PubMed ID: 27404565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity.
    Aher S; Zhu J; Bhagat P; Borse L; Liu X
    Top Curr Chem (Cham); 2024 Feb; 382(1):6. PubMed ID: 38400859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorogenic platinum(IV) complexes as potential predictors for the design of hypoxia-activated platinum(IV) prodrugs.
    Marsh JW; Hacker L; Huang S; Boulet MHC; White JRG; Martin LAW; Yeomans MA; Han HH; Diez-Perez I; Musgrave RA; Hammond EM; Sedgwick AC
    Dalton Trans; 2024 Sep; 53(35):14811-14816. PubMed ID: 39169877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.
    Varbanov HP; Valiahdi SM; Kowol CR; Jakupec MA; Galanski MS; Keppler BK
    Dalton Trans; 2012 Dec; 41(47):14404-14415. PubMed ID: 22886297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX; Wang ZF; Qin QP; Zou BQ; Liang H
    Dalton Trans; 2020 Feb; 49(5):1613-1619. PubMed ID: 31942585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pt(IV) Anticancer Prodrugs - A Tale of Mice and Men.
    Gibson D
    ChemMedChem; 2021 Jul; 16(14):2188-2191. PubMed ID: 33928760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum(iv) anticancer prodrugs - hypotheses and facts.
    Gibson D
    Dalton Trans; 2016 Aug; 45(33):12983-91. PubMed ID: 27214873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.